Oral Inflammation and Ulceration Lesions
Oral Inflammation and Ulceration Lesions
Oral Inflammation and Ulceration Lesions
LESIONS
TUBERCULOSIS:
• Primary tuberculosis of the oral mucosa is rare.
• Most lesions spread from the lung, with bacilli carried in sputum and entering
small breaks in the mucosa.
• Produce irregular, painful ulcers, mostly on the tongue. Caseating
granulomatous inflammation is typical.
SYPHILIS:
• Primary syphilitic chancres may form on the lips, tongue or oropharyngeal
mucosa after contact with an infectious lesion.
• Regional lymphadenitis follows and heals by itself in a few weeks. A
diffuse mucocutaneous eruption of the secondary stage follows. Syphilitic
lesions in the oral mucosa are multiple gray-white patches overlying
ulcerated surfaces. They may remit and also recur spontaneously.
• Gummas on the palate and tongue may appear years after initial infection
as firm nodular masses that ulcerate and may cause palatal perforation.
ACTINOMYCOSIS:
• Actinomycetes are common denizens of the oral cavity in healthy people.
• Invasive actinomycosis is most often caused by Actinomyces bovis, but
Actinomyces israelii is sometimes seen.
• The organisms produce chronic granulomatous inflammation and
abscesses that drain by fistula formation, with suppurative infection
containing characteristic yellow “sulfur granules.”
• In cervicofacial actinomycosis, soft tissue infection may extend to
adjacent bones, most often to the mandible.
HUMAN PAPILLOMAVIRUS (HPV)–RELATED DISEASES:
• The HPV family of viruses causes epithelial proliferations including
papillomas (e.g., sinonasal, Schneiderian papillomas and other papillomas
of upper aerodigestive tract sites).
• “High-risk” HPV, mainly types 16 and 18, as well as 31, 33 and 35, is
strongly associated with oropharyngeal squamous cell carcinoma.
HUMAN HERPES VIRUS 8 (HHV8):
• HHV8 is associated with Kaposi sarcoma (KS). This tumor occurs most
often in the skin but can also involve, among other places, the tongue and
oral cavity. These tumors resemble their cutaneous counterparts.
Immunosuppressed patients (e.g., transplant recipients or patients infected
with HIV-1) are at very high risk for this disease. It is also seen in